Y DR, Lopez-Terrada D, De Leon AP, Luo Y, Jorgensen J

Y DR, Lopez-Terrada D, De Leon AP, Luo Y, Jorgensen J, Schwartz MR, Chang CC: Restricted kappa/lambda light chain ratio by flow cytometry in germinal center B cells in Hashimoto thyroiditis. Am J Clin Pathol 2006, 125(1):428. 52. Martin-Subero JI, Klapper W, Sotnikova A, Callet-Bauchu E, Harder L, Bastard C, Schmitz R, Grohmann S, Hoppner J, Riemke J, Barth TF, Berger F, Bernd HW, Claviez A, Gesk S, Frank GA, Kaplanskaya IB, Moller P, Parwaresch RM, Rudiger T, Stein H, Kuppers R, Hansmann ML, Siebert R, Deutsche Krebshilfe Network Project Molecular Mechanisms in Malignant L: Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Cancer Res 2006, 66(21):103320338.Szczepanek-Parulska et al. Diagnostic Pathology 2013, eight:116 http://www.diagnosticpathology.org/content/8/1/Page 8 of53. Zeppa P, Cozzolino I, Peluso AL, Troncone G, Lucariello A, Picardi M, Carella C, Pane F, Vetrani A, Palombini L: Cytologic, flow cytometry, and molecular assessment of lymphoid infiltrate in fine-needle cytology samples of Hashimoto thyroiditis. Cancer 2009, 117(3):17484. 54. Joos S, Kupper M, Ohl S, von Bonin F, Mechtersheimer G, Bentz M, Marynen P, Moller P, Pfreundschuh M, Trumper L, Lichter P: Genomic imbalances such as amplification in the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 2000, 60(three):54952. 55. Joos S, Menz CK, Wrobel G, Siebert R, Gesk S, Ohl S, Mechtersheimer G, Trumper L, Moller P, Lichter P, Barth TF: Classical Hodgkin lymphoma is characterized by recurrent copy number gains on the brief arm of chromosome two. Blood 2002, 99(four):1381387. 56. Joos S, Granzow M, Holtgreve-Grez H, Siebert R, Harder L, Martin-Subero JI, Wolf J, Adamowicz M, Barth TF, Lichter P, Jauch A: Hodgkin’s lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p like REL and JAK2. Int J Cancer 2003, 103(four):48995. 57. Martin-Subero JI, Gesk S, Tougher L, Sonoki T, Tucker PW, Schlegelberger B, Grote W, Novo FJ, Calasanz MJ, Hansmann ML, Dyer MJ, Siebert R: Recurrent involvement of your REL and BCL11A loci in classical Hodgkin lymphoma.Periplocin site Blood 2002, 99(four):1474477. 58. Baschieri L, Castagna M, Fierabracci A, Antonelli A, Del Guerra P, Squartini F: Distribution of calcitonin- and somatostatin-containing cells in thyroid lymphoma and in Hashimoto’s thyroiditis.Amentoflavone References Appl Pathol 1989, 7(2):9904.PMID:23319057 59. Linch DC, Gosden RG, Tulandi T, Tan SL, Hancock SL: Hodgkin’s lymphoma: choice of therapy and late complications. Hematology Am Soc Hematol Educ Program 2000, 2000(no. 1):20521. ASH Education Book January 1, 2000. 60. Kuppers R, Engert A, Hansmann ML: Hodgkin lymphoma. J Clin Invest 2012, 122(ten):3439447. 61. Kuppers R: New insights within the biology of Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2012, 2012:32834. 62. Thomas RM: Hodgkin’s lymphoma presenting as an abscess in thyroid gland. Indian J Pathol Microbiol 2012, 55(1):12224. 63. Raemaekers JM, van der Maazen RW: Hodgkin’s lymphoma: news from an old disease. Neth J Med 2008, 66(11):45766. 64. Barros MH, Vera-Lozada G, Soares FA, Niedobitek G, Hassan R: Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection. Int J Cancer 2012, 131(five):1142152.doi:ten.1186/1746-1596-8-116 Cite this article as: Szczepanek-Parulska et al.: Thyroid nodule as a 1st manifestation of Hodgkin lymphoma eport of two situations and literature review. Diagno.